journal article·2016-10-10

New Visible-Light Photoinitiating System for Improved Print Fidelity in Gelatin-Based Bioinks

Khoon S. Lim, Benjamin S. Schon, Naveen V. Mekhileri, Gabriella C. J. Brown, Catherine M. Chia, Sujay Prabakar, Gary J. Hooper, Tim B. F. Woodfield

Publisher page

Abstract

Oxygen inhibition is a phenomenon that directly impacts the print fidelity of 3D biofabricated and photopolymerized hydrogel constructs. It typically results in the undesirable physical collapse of fabricated constructs due to impaired cross-linking, and is an issue that generally remains unreported in the literature. In this study, we describe a systematic approach to minimizing oxygen inhibition in photopolymerized gelatin-methacryloyl (Gel-MA)-based hydrogel constructs, by comparing a new visible-light initiating system, Vis + ruthenium (Ru)/sodium persulfate (SPS) to more conventionally adopted ultraviolet (UV) + Irgacure 2959 system. For both systems, increasing photoinitiator concentration and light irradiation intensity successfully reduced oxygen inhibition. However, the UV + I2959 system was detrimental to cells at both high I2959 concentrations and UV light irradiation intensities. The Vis + Ru/SPS system yielded better cell cyto-compatibility, where encapsulated cells remained >85% viable even at high Ru/SPS concentrations and visible-light irradiation intensities for up to 21 days, further highlighting the potential of this system to biofabricate cell-laden constructs with high shape fidelity, cell viability, and metabolic activity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Additive Manufacturing and 3D Printing Technologies · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Department of Orthopaedics Surgery and Musculoskeletal Medicine, University of Otago Christchurch, Christchurch 8011, New Zealand

The MacDiarmid Institute for Advanced Materials and Nanotechnology, Victoria University of Wellington, Wellington 6140, New Zealand

LASRA, Fitzherbert Science Centre, Manawatu-Wanganui, Wellington 6140, New Zealand

Funding

Health Research Council of New Zealand · Royal Society of New Zealand

References (52)

Show source-provided references
1. 10.1039/c3tb21280g10.1039/c3tb21280g ↗
2. 10.1007/s10439-015-1280-010.1007/s10439-015-1280-0 ↗
3. 10.1089/10763270175333764510.1089/107632701753337645 ↗
4. 10.1126/science.849352910.1126/science.8493529 ↗
5. 10.1001/archsurg.1988.0140029002700310.1001/archsurg.1988.01400290027003 ↗
6. 10.1016/j.biomaterials.2003.10.05610.1016/j.biomaterials.2003.10.056 ↗
7. 10.1088/1758-5090/7/3/03500210.1088/1758-5090/7/3/035002 ↗
8. 10.1016/j.ijpharm.2015.10.05510.1016/j.ijpharm.2015.10.055 ↗
9. 10.1088/1758-5082/6/3/03500610.1088/1758-5082/6/3/035006 ↗
10. 10.1016/j.actbio.2015.06.03210.1016/j.actbio.2015.06.032 ↗
11. 10.1007/s10439-016-1609-310.1007/s10439-016-1609-3 ↗
12. 10.1016/j.mattod.2013.11.01710.1016/j.mattod.2013.11.017 ↗
13. 10.1002/term.163510.1002/term.1635 ↗
14. 10.1088/1758-5090/8/1/01300110.1088/1758-5090/8/1/013001 ↗
15. 10.1002/mabi.20110029210.1002/mabi.201100292 ↗
16. 10.1002/mabi.20150012110.1002/mabi.201500121 ↗
17. 10.1080/09205063.2014.95003310.1080/09205063.2014.950033 ↗
18. 10.1002/mabi.20120047110.1002/mabi.201200471 ↗
19. 10.1039/C4LC00030G10.1039/C4LC00030G ↗
20. 10.1016/j.biomaterials.2013.06.00510.1016/j.biomaterials.2013.06.005 ↗
21. 10.1016/j.biomaterials.2010.03.06410.1016/j.biomaterials.2010.03.064 ↗
22. 10.1021/bm990017d10.1021/bm990017d ↗
23. 10.1039/c0sm00697a10.1039/c0sm00697a ↗
24. 10.1016/j.actbio.2015.08.03810.1016/j.actbio.2015.08.038 ↗
25. 10.1016/j.tibtech.2016.01.00210.1016/j.tibtech.2016.01.002 ↗
26. 10.1186/1477-3163-4-1110.1186/1477-3163-4-11 ↗
27. 10.1002/(SICI)1097-4636(2000)53:3<258::AID-JBM11>3.3.CO;2-F10.1002/(SICI)1097-4636(2000)53:3<258::AID-JBM11>3.3.CO;2-F ↗
28. Choi B · 2016
29. 10.1016/j.actbio.2012.01.02910.1016/j.actbio.2012.01.029 ↗
30. 10.1016/S0032-3861(03)00568-810.1016/S0032-3861(03)00568-8 ↗
31. 10.1016/j.arabjc.2014.03.00810.1016/j.arabjc.2014.03.008 ↗
32. 10.1002/marc.20120060510.1002/marc.201200605 ↗
33. 10.1016/j.biomaterials.2009.08.05510.1016/j.biomaterials.2009.08.055 ↗
34. 10.1038/srep0445710.1038/srep04457 ↗
35. 10.1039/c3tb21280g10.1039/c3tb21280g ↗
36. 10.1016/S0300-9440(03)00120-610.1016/S0300-9440(03)00120-6 ↗
37. 10.1021/ma00148a03410.1021/ma00148a034 ↗
38. 10.1089/ten.tea.2014.036210.1089/ten.tea.2014.0362 ↗
39. 10.1038/ncomms793310.1038/ncomms7933 ↗
40. 10.1038/nprot.2016.03710.1038/nprot.2016.037 ↗
41. 10.1089/ten.tea.2014.069110.1089/ten.tea.2014.0691 ↗
42. 10.1063/1.481671410.1063/1.4816714 ↗
43. 10.1039/9781782620075-0001510.1039/9781782620075-00015 ↗
44. 10.1163/15685620074380510.1163/156856200743805 ↗
45. 10.1089/ten.teb.2007.033210.1089/ten.teb.2007.0332 ↗
46. 10.1016/S0142-9612(02)00093-510.1016/S0142-9612(02)00093-5 ↗
47. 10.1016/S1074-5521(00)00020-X10.1016/S1074-5521(00)00020-X ↗
48. 10.1038/icb.1978.3010.1038/icb.1978.30 ↗
49. 10.1088/1758-5082/6/2/02410510.1088/1758-5082/6/2/024105 ↗
50. 10.1002/adma.20150331010.1002/adma.201503310 ↗
51. 10.1021/acsbiomaterials.6b0015810.1021/acsbiomaterials.6b00158 ↗
52. 10.1016/j.biomaterials.2013.09.07810.1016/j.biomaterials.2013.09.078 ↗